Based on clinical studies showing that expression of CEMIP is inversely correlated with cancer survival rate in patients with breast cancer, colon cancer, and gastric cancer [1, 4, 5], CEMIP could positively affect cancer cell invasion through enhanced cell migration. This evidence concerns the gene CEMIP and breast cancer.